Vivakor, Inc.
VIVK, VIVKDOther · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $104.4M | $89.8M | $59.3M | $28.1M | $1.1M | $1.5M |
| Operating income | −$63.8M | −$22.0M | −$6.3M | −$22.7M | −$6.9M | −$4.8M |
| Net income | −$110.2M | −$26.4M | −$10.8M | −$20.2M | −$7.3M | −$2.9M |
| Total assets | $113.5M | $241.0M | $71.2M | $76.3M | $47.7M | $42.3M |
| Total liabilities | $76.3M | $125.9M | $54.0M | $49.3M | $20.2M | $16.3M |
| Equity | $41.3M | $119.2M | $17.2M | $18.9M | $22.5M | $15.4M |
| EPS (diluted) | $-318.01 | $-151.32 | $-0.56 | — | $-0.46 | $-0.23 |
| Shares out. | 44.6M | 27.7M | 18.1M | 15.0M | 18.1M | 11.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −61.1%
- Net margin
- −105.6%
- Return on equity
- −266.8%
- Return on assets
- −97.1%
- Return on capital (ROCE)
- −122.8%
- Liabilities / assets
- 67.2%
- Debt / equity
- 1.85×
- Book value / share
- $0.93
- Revenue growth (YoY)
- 16.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -12.16distress
- Accruals / assets
- −83.2%clean
- Beneish M-Score
- -6.40normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Hawley Kimberly AnnOfficer — CFO | Nov 26, 2025 | Grant | 25,000 | $0.13 |
| Ballengee James H.Officer — CEO | Nov 10, 2025 | J | 3.0M | $0.17 |
| Ballengee James H.Officer — Chairman, President, & CEO | Dec 2, 2024 | Grant | 369,740 | $0.60 |
| Ballengee James H.Officer — Chairman, President, & CEO | Apr 4, 2024 | Grant | 422,199 | $0.59 |
| Knapp PatrickOfficer — EVP, Gen. Counsel, & Secretary | Jul 3, 2024 | Grant | 140,190 | $1.78 |
| Ballengee James H.Officer — Chief Executive Officer | May 23, 2024 | Buy | 30,744 | $1.29 |
| Ballengee James H.Officer — Chief Executive Officer | Apr 23, 2024 | Buy | 54,500 | $1.44 |
| Ballengee James H.Officer — Chief Executive Officer | Apr 19, 2024 | Buy | 30,000 | $1.12 |
| Ballengee James H.Officer — Chief Executive Officer | Nov 10, 2023 | J | 7.0M | $1.42 |
| Ballengee James H.Officer — Chief Executive Officer | Nov 25, 2022 | Grant | 55,300 | $0.99 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureMay 14, 2026
- Entered a material agreement · Unregistered equity saleMay 12, 2026
- Regulation FD disclosure · Other material eventMay 5, 2026
- Delisting / listing-standard noticeApr 28, 2026
- Amended charter or bylaws · Regulation FD disclosure · Other material eventMar 27, 2026
- Regulation FD disclosure · Other material eventMar 19, 2026
- Entered a material agreement · Unregistered equity saleMar 5, 2026
- Entered a material agreementFeb 5, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.